https://www.selleckchem.com/pr....oducts/abraxane-nab-
The median overall survival for all patients was 14 months. When we compared the median survival of patients who had any adjuvant treatment with the patients treated without any adjuvant therapy, we found a significant statistical difference between the groups (32.4 vs 6.5 months; P = 0.00. In addition, survival of each treatment group was also compared with each other but we did not find any significant statistical difference. Conclusions Our result suggests that any adjuvant therapy in the treatment of pancreatic can
Like
Comment
Share
